AI

The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.

The aim is to apply AI to deliver more personalized care and derive insights on population health and disease progression.  

The editors of Healthcare IT News, Healthcare Finance News and MobiHealthNews discuss AI's value in 2025 in areas such as assisting with administrative tasks, drug discovery, documentation, precision medicine and imaging.

The editors of Healthcare IT News, Healthcare Finance News and MobiHealthNews discuss the telehealth bill that was scuttled in 2024, as well as what's ahead in 2025 regarding the RPM market, physicians' pay schedule and cybersecurity policy.

Chief AI officers can help organizations address clinical issues, such as C. diff inspections and sepsis, and broader needs like scheduling, resources and improving the backend, says Zachary Durst, IT practice consultant at WittKieffer.

The guidance recommends a PCCP describe the planned AI-DSF modifications, the associated methodology to develop, validate and implement them, and assess the impact of the changes.  

The company will use the funds to try and level the playing field between payers and providers.

The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.

They will collaborate on identifying novel therapeutic drug candidates for lung cancer.

The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.